Truist Securities analyst Scot Ciccarelli maintains Dollar Gen (NYSE:DG) with a Hold and raises the price target from $227 to $262.
Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac
U.S. District Judge Robin Rosenberg in Florida has dismissed about 50,000 claims associated with GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE), Sanofi SA (NASDAQ:SNY), and Boehringer Ingelheim, claiming…